| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |